Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD

Molecular Medicine Reports

Volumn 6, Issue 3, 2012, Pages 525-530

  Tu, Kangsheng ^a   Zheng, Xin ^a   Yin, Guozhi ^a   Zan, Xianfeng ^a   Yao, Yingmin ^a   Liu, Qingguang ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Metabolic syndrome; Non alcoholic fatty liver disease; Sterol regulatory element binding protein; Ubiquitin ligase (E3)

Indexed keywords

F BOX AND WD REPEAT DOMAIN CONTAINING 7; MESSENGER RNA; PEPTIDES AND PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IMMUNOHISTOCHEMISTRY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; F-BOX PROTEINS; FATTY LIVER; IMMUNOHISTOCHEMISTRY; LIVER; MICE; MICE, INBRED C57BL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UBIQUITIN-PROTEIN LIGASES;

EID: 84865183905     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.953     Document Type: Article

References (20)

1. Hamaguchi E, Takamura T, Sakurai M, et al: Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis. Diabetes Care 33: 284-286, 2010.
2. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H and Svegliati-Baroni G: From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42: 320-330, 2010.
3. Ogawa T, Fujii H, Yoshizato K and Kawada N: A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits. Am J Pathol 177: 153-165, 2010.
4. Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y and Uno M: Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 132: 282-293, 2007. (Pubitemid 46108737)
5. Bugianesi E, Moscatiello S, Ciaravella MF and Marchesini G: Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 16: 1941-1951, 2010.
6. Nakamuta M, Kohjima M, Morizono S, et al: Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 16: 631-635, 2005.
7. Foufelle F and Ferré P: New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366: 377-391, 2002. (Pubitemid 35001682)
8. Hagen RM, Rodriguez-Cuenca S and Vidal-Puig A: An allostatic control of membrane lipid composition by SREBP1. FEBS Lett 584: 2689-2698, 2010.
9. Nakayama H, Otabe S, Ueno T, et al: Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. Metabolism 56: 470-475, 2007. (Pubitemid 46427843)
10. Sundqvist A, Bengoechea-Alonso MT, Ye X, et al: Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7. Cell Metab 1: 379-391, 2005. (Pubitemid 43960622)
11. Welcker M and Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83-93, 2008. (Pubitemid 351161321)
12. Kirpich IA, Gobejishvili LN, Bon Homme M, et al: Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. J Nutr Biochem 22: 38-45, 2011.
13. Onoyama I, Suzuki A, Matsumoto A, et al: Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. J Clin Invest 121: 342-354, 2010.
14. Livnat-Levanon N and Glickman MH: Ubiquitin-proteasome system and mitochondria-reciprocity. Biochim Biophys Acta 1809: 80-87, 2011.
15. Chan NC, Salazar AM, Pham AH, et al: Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20: 1726-1737, 2011.
16. Willis MS, Townley-Tilson WH, Kang EY, Homeister JW and Patterson C: Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease. Circ Res 106: 463-478, 2010.
17. Bashir T and Pagano M: Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. Adv Cancer Res 88: 101-144, 2003. (Pubitemid 36343280)
18. Sundaram M and Greenwald I: Suppressors of a lin-12 hypomorph define genes that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics 135: 765-783, 1993. (Pubitemid 23324820)
19. Nash P, Tang X, Orlicky S, et al: Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414: 514-521, 2001. (Pubitemid 33131529)
20. Bengoechea-Alonso MT and Ericsson J: SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 19: 215-222, 2007. (Pubitemid 46386402)